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 This study examined the process of sexual recovery after surgical treatment for 
prostate cancer in a sample of 527 men in relationships, both in the context of their 
broadly measured Expanded Prostate Cancer Index Composite (EPIC) sexual functioning 
summary scores (Aim 1) and in frequencies of sexual activity (Aim 2). Across a period of 
5 years, men submitted data up to 10 times about a variety of factors related to sexual 
quality of life (e.g., levels of sexual desire). Hierarchical linear growth modeling was 
used to estimate individual growth trajectories for each outcome, allowing for 
simultaneous examination of intraindividual and interindividual variability. Although 
everyone experienced a decrement to both outcomes immediately after surgery, results 
suggested that younger age, higher pretreatment sexual functioning and frequencies of 
sexual activity, and receiving nerve-sparing procedures were associated with better 
sexual functioning and higher frequency of sexual activity several months after surgery. 
Most men’s levels of sexual functioning improved over time, though those with higher 
pretreatment sexual functioning increased at a faster rate. Although on average there was 
a slight, steady improvement over time in frequencies of sexual activity, individual men 
also varied from month-to-month around their own average levels of sexual activity 
depending on changes in sexual desire, confidence in satisfying a partner, perceived 
erectile ability, perceived orgasm ability, and whether or not they used sexual aids that 
 
iv 
month. These findings are discussed in the context of methodological and clinical 
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Prostate cancer is one of the most common cancers in men (CDC, 2011) and is 
typically characterized as slow-growing, initially asymptomatic, and often still localized 
at the time of detection (Howlader et al., 2012). This is a cancer with impressive 
survivorship rates: nearly 100% of men are still alive at 5 years and 91% at 10 years 
(Galbraith et al., 2011) from detection. Though prostate cancer has traditionally been 
identified primarily in older men (e.g., Ahmedin et al., 2004), the age of survivors is 
trending younger, with a recent study finding the mean age of new diagnoses to be 63.6 
(Glass et al., 2013). Further, most men are in a romantic relationship at the time of 
diagnosis (e.g., Davison & Breckon, 2012). Thus, men are now likely to be diagnosed 
with prostate cancer at a period when they still expect to have many years of high quality 
of life remaining to spend with their partners.  
Approaches for screening and treating prostate cancer have evolved rapidly over the 
past few decades, which have influenced the complexity of navigating the disease. As the 
medical model has shifted towards a patient-centered approach, patients have become 
increasingly involved in treatment decision making (Kon, 2010; Maliski et al., 2002) and 
a greater emphasis has been placed on measuring and improving psychosocial outcomes 
(Weber & Sherwill-Navarro, 2005). For some, increased agency for complex health 
conditions like prostate cancer can be overwhelming, due to the need to simultaneously 




information gathering and attending numerous medical appointments before making a 
decision (Holmboe & Concato, 2000). Further complicating this process, advancements 
in the number, efficacy, and safety of treatment options have resulted in many treatments 
from which to choose (National Cancer Institute, 2014).  
The treatment of focus in the current study, radical prostatectomy (RP), involves 
removing the prostate gland during a surgical procedure, and recent options for 
minimally invasive, nerve-sparing approaches to attempt to decrease complications have 
resulted in this treatment remaining a common choice (e.g., O’Shaughnessy et al., 2013). 
Unfortunately, each of the available options, including RP, have been shown to cause at 
least temporary side effects (i.e., sexual, urinary, and bowel problems), which can 
significantly impact quality of life for both partners and may linger for years or become 
permanent for some men (e.g., Beck et al., 2009; Song et al., 2011). Considering the 
common consequences of treating this illness, it is important that doctors and their 
patients understand both the risks of each treatment option and how various factors 
influence quality of life after treatment, in order to ensure an educated treatment decision.  
 
Existing Literature on Sexual Quality of Life After 
Treatment for Prostate Cancer 
The side effect that has garnered the most research interest is sexual dysfunction. 
This is the most common long-term side effect and considered by most men and their 
partners to be the most distressing (Bokhour et al., 2001; Clark et al., 1999; 
O’Shaughnessy et al., 2013), particularly when they are surprised by the severity and 
time course of sexual problems after treatment (Mohamed et al., 2012). Research 
suggests that sexual problems after surgery may negatively affect multiple types of 
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health-related quality of life, including significant emotional distress (e.g., Davison et al., 
2007); overall health and general physical functioning (e.g., Brassel et al., 2013); 
relationship satisfaction (Yoo, Bartle-Haring, Day, & Gangamma, 2014); and depression 
and anxiety (e.g., Nelson et al., 2007; 2011). Research further suggests that unrealistic 
expectations about sexual functioning after treatment may contribute to treatment regret 
(e.g., Clark et al., 2003).  
Thus, it is critical to find ways to improve men’s sexual quality of life after 
prostate cancer, particularly by identifying interventions to resolve sexual problems or 
cope with treatment-related changes (Reese et al., 2010). It would also be valuable to 
increase our understanding of the typical recovery process in order to provide couples 
with more accurate postsurgery expectations when making treatment decisions (Paisch et 
al., 2016; Wittmann et al., 2015). If there are individual differences and/or treatment 
factors that affect the rate of recovery, couples could use that information to inform their 
treatment decision. For example, if a subset of men is unlikely to experience any 
significant recovery for as long as a year after treatment, it is important they be prepared 
for such an outcome. This information would also be useful for health care providers, 
both in helping patients make a treatment decision and in evaluating their recovery.  
 Although there are a multitude of published findings on sexual and erectile 
functioning after surgical treatment for prostate cancer, significant variability has been 
found within and across studies that has limited their use in providing men with guidance 
related to the recovery process (Brassel et al., 2013; Lubeck et al., 1999; Mulhall, 2009). 
Overwhelmingly, the existing research has examined sexual functioning at a single point 
in time after treatment (e.g., 12 months) and compared it with functioning immediately 
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after treatment. These studies demonstrate clearly that most men experience some 
decrement in functioning immediately after surgery (see Mulhall, 2009); however, 
research on other points in time after treatment have demonstrated the substantial 
individual differences between men. Although some studies have concluded that men’s 
levels of sexual functioning early after treatment are predictive of sexual functioning 
several years later, studies in this area rarely measure men far enough into the recovery 
period to accurately characterize that process over time (e.g., Stensvold et al., 2013). The 
few recent studies that have included several points of follow-up (e.g., 1 year and 2 years) 
are consistent with conclusions that many men may continue to change over time (e.g., 
Bokhour et al., 2001; Brassel et al., 2013).  
Without following and repeatedly measuring the same men’s sexual functioning 
across numerous points of follow-up, it would be challenging to statistically characterize 
their trajectories of recovery, make conclusions about the moderating effect of individual 
difference variables on those trajectories, and predict with any accuracy what newly 
diagnosed men might expect after treatment in terms of functioning. Using longitudinal 
data analytic approaches for research in this area would allow a robust examination of the 
recovery process over time, including variations in rates of recovery based on the 
influence of within-individual and between-men variables. Additionally, given that fully 
understanding the process of recovery after treatment would involve multiple 
observations for each man and then comparing groups, the data are considered to be 
nested.  Failing to account for dependency in nested data can have consequences for the 
accuracy of the estimates and for the interpretation of the results (Raudenbush & Bryk, 
2011). Longitudinal analytic procedures, such as hierarchical linear growth modeling, 
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have the ability to account for the dependency in nested data, and can use each individual 
man’s points of follow-up to generate a trajectory for his data that can then be used to 
identify trends in the data.  
In considering the individual difference variables to include in longitudinal studies, 
the existing research provides some evidence of factors that appeared to influence sexual 
functioning at certain points after surgery (e.g., a benefit of younger age found at 24 
months; Moskovic et al., 2011). For the influence of patient age, others have found this 
same result at different points in time after treatment (e.g., Rabbani et al., 2000). It is 
possible that these studies have identified uniquely relevant points in time when age 
influences sexual functioning, but age may also be influential in a more global way not 
yet examined, such as in men’s trajectory of recovery (i.e., rates of recovery). Including 
these influential factors in more sophisticated analyses may help us better understand the 
duration or timing of their influence after surgery, as well as clarify other discrepancies in 
the existing research. So, although prostate cancer studies have not examined whether 
older men may recover at a different rate than younger men, it is well established in other 
health research that older men, due to various health factors (e.g., decreased blood flow, 
comorbidities), experience a slower return to functioning after illnesses and medical 
procedures (Sigler et al., 2003). This suggests that we might find that older men would 
recover their sexual functioning after RP at a slower rate than younger men.  
Relatedly, sexual functioning prior to treatment likely influences the rate of 
recovery. Since previous research has found that men with lower pretreatment 
functioning continue to be lower functioning at different points after surgery than those 
with higher pretreatment functioning (Moskovic et al., 2011; Rabbani et al., 2000; Song 
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et al., 2011), it may be that low pretreatment functioning predicts a flatter trajectory of 
recovery after surgery than would be observed in those with higher pretreatment 
functioning. Finally, surgical treatment characteristics may play a role in the rate of 
recovery of sexual functioning. When medically appropriate, most men undergo at least 
partial nerve-sparing procedures (also called unilateral and modified nerve-sparing), with 
a recent study (Stensvold et al., 2013) reporting only 11% received no nerve-sparing 
while 37% received unilateral nerve-sparing and 52% bilateral nerve-sparing. Several 
studies have found that degree of nerve-sparing is positively related to men’s sexual 
functioning at various points after treatment (e.g., Moskovic et al., 2011; Rabbani et al., 
2000; Stensvold et al., 2013). It is unclear from existing research how sparing the nerves 
may specifically influence posttreatment functioning, such as whether it may result in 
more rapid recovery of their sexual functioning. However, one study found that bilateral 
nerve sparing resulted in more rapid recovery of urinary control than did non-nerve-
sparing procedures, likely due to sparing nerves also implicated in sexual functioning 
(e.g., inferior hypogastric plexus, Hollabaugh et al., 1998). Thus, it would be expected 
that an increased degree of nerve sparing would result in a faster rate of recovery.  
There is conflicting evidence regarding the presumed superiority of robotic-
assisted procedures in producing better posttreatment sexual functioning when compared 
to traditional open procedures (e.g., Ball et al., 2006; Menon et al., 2007; Mulhall, 2009). 
The argument is that robotic-assisted procedures improve surgeon visibility and 
precision, while decreasing error, resulting in decreased blood loss and more rapid 
physical recovery overall (Menon et al., 2002), but it is not clear how or if that would 
translate to better long-term sexual functioning. Even if robotic-assisted techniques are 
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not reliably more effective in maintaining sexual function, they may result in quicker 
return to function than open surgical approaches. Therefore, it would be important to 
examine whether robotic procedures result in a faster rate of sexual functioning recovery 
after treatment than traditional procedures.  
In summary, multilevel longitudinal studies are necessary to (1) increase our 
understanding of the sexual recovery process after surgery and to (2) more robustly 
examine the influence of the above individual difference factors on men’s recovery rates 
for sexual functioning. Doing so would improve the accuracy of the information provided 
to men about what to expect across time after surgery.   
 
Sexual Activity and Health-Related Quality of Life 
 
We now focus on a related topic rarely directly examined in the prostate cancer 
literature: frequency of sexual activity after treatment. Research suggests that prior to 
diagnosis many couples are still engaging in sexual activity and view a change to be of 
significant concern (e.g., Bokhour et al., 2001; Galbraith et al., 2011). For most couples 
making a treatment decision, considering the potential loss of their sexual activity can be 
an important aspect of that choice (Holmboe & Concato, 2000). Indeed, continued sexual 
intimacy into the later stages of life has been shown to be important for emotional well-
being and physical health for many older adults (Lindau et al., 2007; Willert & Semans, 
2000). For many in late adulthood, sexual activity continues to be an important way of 
expressing love (e.g., Campbell & Huff, 1995; Katz, 2015). Recent work has especially 
highlighted the importance of learning more about the factors that influence a couple’s 
frequency of sexual activity (including, but not limited to, sexual intercourse) after 
prostate cancer treatment in order to better understand the quality of life implications of 
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their treatment (e.g., Wittmann et al., 2015). Specifically, some have suggested that non-
intercourse sexual activity and intimacy (such as communication about sex and physical 
affection) with a partner after treatment might serve as a buffer against some of the 
negative aspects of sexual dysfunction (e.g., Badr & Taylor, 2008; Clark et al., 2003; 
Manne & Badr, 2008; Reese et al., 2010).  
In the prostate cancer literature, the most common sexual quality of life outcome 
examined after treatment is the broad term sexual functioning. The measures examining 
this construct usually include multiple indicators, typically focusing on quality of 
erections and ability to successfully complete penile-vaginal intercourse (e.g., EPIC; Wei, 
Dunn, Litwin, Sandler, & Sanda, 2000). However, this heavy emphasis on penile-vaginal 
intercourse and, more often, solely on erectile capacity without measuring actual sexual 
expression, overlooks the possibility that men could be engaging in frequent, satisfying 
sexual activity without it being captured by these measures. Currently, only one measure 
(the long version of the EPIC; Wei et al., 2000) asks about the frequency of any sexual 
activity, and as a single item contributing to a summary score from nine items, has 
relatively little impact on that score. Thus, the influence of individual components on that 
total score are masked, and it is possible that ratings on individual items could fluctuate 
without an observed change in the overall score. From a clinical standpoint, it is 
challenging to meaningfully interpret changes in one’s overall sexual functioning score 
over time given that it is a composite of many factors, both physiological and 
psychological, which may not all be equally related to men’s experience of his sexual 
quality of life. For example, since a man could have an improvement in REM sleep 
erections that influences the overall score, it might appear as if he is having better 
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functioning without any meaningful improvements to his reported experience. 
Unfortunately, it is usually only the total score that gets considered in the research in this 
area, such that when couples inquire about what the quality of their sex lives will look 
like after cancer, there is little specific information available (Wittmann et al., 2015). 
Further, while men recovering from prostate cancer treatment may have a 
reduction in erectile capacity, this does not preclude them from engaging in certain sexual 
activities with their partners, and couples who have adjusted well to a decrement in 
erectile capacity through alternative types of satisfying sexual intimacy would likely be 
missed in these types of studies. Intervention research in this area has also commonly 
relied on these same broad sexual functioning outcomes when their goal is specifically to 
improve couples’ sexual intimacy and satisfaction (Chambers et al., 2015). Examining 
rates and quality of sexual activity may better capture meaningful changes to sexual 
expression that couples may experience as a result of surgery, and allow for identifying 
any moderating factors. Thus far, only a few qualitative studies have directly examined 
sexual activity after prostate cancer treatment, and have primarily done so by 
interviewing couples (e.g., Wittmann et al., 2015). While contributing valuable 
information to the literature, this approach has methodological limitations, is time-
consuming, and necessarily results in relatively small samples.  
As mentioned above, there are a variety of reasons that patterns of sexual activity 
after cancer treatment might be an important research target. Considering that couples’ 
concerns are strongly related to minimizing the loss of sexual intimacy (e.g., Bokhour et 
al., 2001; Clark et al., 2003; Hordern & Street, 2007), there is little available information 
about the factors that are related to higher frequency of sexual activity after prostate 
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cancer treatment. The return to satisfying rates of sexual activity (irrespective of the 
degree of coital functionality) is unlikely to be the same for all men. It is likely that men 
may see an increase in frequency of sexual activity at different rates after surgery, 
possibly due to some of the same factors as identified in sexual functioning research (e.g., 
age). Further, research suggests that rates of sexual activity across time are somewhat 
variable for older men and are related to factors such as sexual desire and sexual self-
esteem (e.g., Kontula & Haavio-Mannila, 2009).  
There may be other factors than erectile capacity that influence rates of sexual 
activity after prostate cancer within an individual, since it is quite possible for men to 
engage in sexual activity with a partner without an erection strong enough for intercourse, 
such as oral-genital or manual-genital stimulation. It is also possible for men to orgasm 
without a full erection or even in the absence of an erection (Koeman et al., 1996). In 
fact, techniques used in some prostate cancer quality of life interventions focus on coping 
with changes in pleasure and intimacy through alternative sexual activities (e.g., Canada 
et al., 2005). Investigating the influence of additional factors (other than erectile capacity) 
that influence men’s frequency of sexual activity after treatment would be valuable to 
men making treatment decisions and to those developing treatment interventions 
targeting sexual activity after treatment (e.g., Reese et al., 2010).   
 
Objectives for the Current Study 
 
This project examined the longitudinal trajectories of sexual quality of life after 
surgical treatment of prostate cancer. In particular, an emphasis was placed on two main 
aims: (1) examining the between-men factors that influence rates of recovery for sexual 
functioning and (2) examining both between-men (e.g., pretreatment sexual activity) and 
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within-men factors (e.g., confidence in ability to satisfy partner) that influence the 
frequency of sexual activity over time. In combination, the aims were designed to 
increase the understanding of what accounts for the variability reported across studies in 
men’s sexual quality of life after prostate cancer treatment, with the ultimate goals of 
helping men and their treatment providers make more informed treatment decisions and 
guiding posttreatment interventions. This project sought to improve on methodological 
limitations in previous work by using advanced statistical procedures designed for nested 
longitudinal data.  
 
Aim 1: Trajectories in Sexual Functioning Recovery 
 
This first aim examined the rate of recovery of men’s sexual functioning with two 
questions. First, do men vary in their rate of recovery for sexual functioning after prostate 
cancer treatment? As discussed above, research has found wide variation in sexual 
functioning at various points after treatment, strongly suggesting that men differ in their 
rates of recovery after treatment. Thus, it was hypothesized that there would be variation 
in men’s trajectories of sexual functioning recovery, such that some men would 
experience a faster rate of recovery while other men would experience a slower rate of 
recovery. Second, what factors account for the differences between men in rate of 
recovery? We hypothesized that the following four between-subjects factors would 
influence the rate of sexual functioning recovery: age, pretreatment sexual functioning, 
type of surgical approach (open vs. robotic), and degree of nerve-sparing (none, 
modified, and bilateral). Specifically, it was hypothesized that those younger men with 
better pretreatment sexual functioning who received robotic surgery with a greater degree 
of nerve-sparing would recover sexual functioning at a faster rate than would other men. 
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Aim 2: Factors That Influence Men’s Frequency of Sexual Activity 
 
Sexual activity after prostate cancer treatment has not yet been directly examined 
through measurement over time in the literature, including identification of factors that 
might influence sexual activity over time. This study sought to answer the following 
research questions associated with this. First, is there an association across time between 
time-varying factors (e.g., levels of sexual desire) and frequency of sexual activity?  
Qualitative work in prostate cancer (e.g., Bokhour et al., 2001; Chung & Brock, 2013; 
Clark et al., 2003; O’Shaughnessy et al., 2013; Wittmann et al., 2015; Zaider et al., 
2012), as well as other work focusing on sexuality in older adults (Kontula & Haavio-
Mannila, 2009), has suggested a number of factors that may relate to couple’s frequency 
of sexual activity over time, including self-image and confidence (especially related to 
ability to please a partner), perceived erectile ability, levels of sexual desire, and 
perception of orgasm ability. Further, the use of sexual aids, such as medication and 
injection, improve the ability to engage in a number of sexual activities (Plym et al., 
2014) and are likely related to increased frequency of sexual activity. Thus, it was 
hypothesized that the monthly fluctuations in these five factors would influence men’s 
frequency of sexual activity across time. Specifically, during those months when men 
report higher levels of confidence in ability to please a partner, greater orgasm ability, 
greater sexual desire, greater ability to have an erection, and use of any erectile aids, it 
was hypothesized that they would engage in sexual activity (included, but not limited to, 
intercourse) with a greater frequency than other months.  
Second, do men differ in their frequency of sexual activity over time after 
treatment and what between-subjects factors accounts for those differences? It was 
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hypothesized that increases in the frequency of sexual activity over time would vary as a 
function of age, pretreatment sexual activity, type of surgical approach, and degree of 
nerve sparing. Specifically, it was anticipated that younger men with greater pretreatment 
sexual activity who received robotic surgery with a greater degree of nerve sparing would 






























 The current study utilized the data from an ongoing longitudinal project 
examining health and quality of life outcomes after treatment for prostate cancer. 
Participants were from the Prostate Disease Oriented Team (PDOT) database, maintained 
by medical care providers at the Huntsman Cancer Institute in Salt Lake City, Utah since 
2002. The data used were a subset of participants from the total database who completed 
paper versions of the questionnaires containing all variables of interest. Initial eligibility 
criteria included that men be previously diagnosed with prostate cancer and have 
completed surgical treatment. Since we were primarily examining sexual functioning and 
activity, we included only men who reported having some type of partner (excluded 38 
cases). Given our interest in change over time, we only included respondents who 
contributed at least three data points, as well as pretreatment baseline, on the measures 
and items of interest in this study (excluded 107 cases). The final sample included 527 
participants. This study was approved by the Huntsman Cancer Institute IRB, and use of 
these data falls under that institution’s approval.  
 Participants ranged in age from 43 to 78 (M = 60.81, SD = 6.71). Most were 
Caucasian (97%), with all other ethnicities each amounting to 1% or less of the sample: 
Asian/Asian American/Pacific Islander 1%, Latino/Hispanic 0.8%, Black/African 




Participants were overall highly educated: 37.6% were educated through graduate school, 
another 49.1% attended college and 25.6% of those graduated, and only 13.3% endorsed 




 Participants were initially recruited to the study by their nurse and their medical 
specialist at the “treatment options consultation” after diagnosis, who provided them with 
information about the purpose of the study and asked if they were interested in 
participating. They were told that as part of participation in a longitudinal study through 
HCI, they would be asked to complete a set of questionnaires about their experiences 
with prostate cancer treatment and quality of life. They were told they would be 
contacted at approximately the following points to complete the questionnaires: prior to 
treatment, every 3 months for the 1st year posttreatment (3, 6, 9, and 12 months), every 6 
months during year 2 (18 and 24 months), and then yearly through up to 5 years (36, 48, 
and 60 months). Note that although these were the approximate points at which patients 
were contacted, patients varied in when they returned the packets. They were informed 
that they would not be financially compensated for their participation and that they could 
refuse to participate or drop out at any time without negatively impacting their access to 
medical care. After consenting to participate in the study, men were provided with a 
questionnaire packet, either in person or via mail depending on the patient’s preference, 
to complete and return by the time they proceeded with treatment. The specific date on 
which the patient returned the questionnaire packet was recorded.  
At the time of each point of follow-up, a member of the Huntsman Cancer 
Institute staff contacted them, reminded them of the value of their participation, and 
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either asked them to fill out the packet at their follow-up appointment or mailed them the 
questionnaire packet after urging them to return it promptly. As much as possible, 
patients were prompted to fill out packets around the time of regularly scheduled follow-
up appointments, which usually closely followed the targeted schedule for the study. If 
they did not return the packet within a week, they were reminded via phone. The date 
they returned the questionnaire packets was recorded.  If they missed a given point of 
follow-up, they were asked again at the next point unless they asked to be removed from 
the study. Participant data were entered by members of the research team into a 




 The full questionnaire packet, which included the same items at baseline and all 
follow-up points, consisted of a number of measures designed to gain information about 
men’s demographics, quality of life, and physical functioning following treatment. From 
the battery given to participants, the following was used for this study. 
 
Functioning and Quality of Life 
 
The Sexual Functioning subscale of the long version of the Expanded Prostate 
Cancer Index Composite (EPIC; Wei, Dunn, Litwin, Sandler, & Sanda, 2000) included 
such questions as “How would you describe the usual QUALITY of your erections 
during the past four weeks” on a 1 (very poor to none) to 5 (very good) scale. This 
measure has been shown to have adequate reliability and validity across multiple 
treatment types, including surgery (Wei, Dunn, Litwin, Sandler, & Sanda, 2000), and is 
one of the most commonly used measures to evaluate sexuality quality of life in the 
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literature (Punnen et al., 2013).  
The score from the Sexual Functioning domain was used for Aim 1, in order to be 
comparable with previous research. In order to study this construct independent of the 
frequency of sexual activity (examined in Aim 2), the EPIC Sexual Functioning score 
was calculated without the inclusion of the frequency of sexual activity item. Thus, this 
score was made up of eight items, and was calculated as follows: each item was 
converted to 0-100 scale and then averaged for a total score. For Aim 2, the outcome 
variable was the frequency of sexual activity item, i.e., item 5: “During the last 4 weeks, 
how often did you have any sexual activity?” on a 1 (none at all) to 5 (daily) scale. The 
predictors included the following items from this measure: “How would you rate each of 
the following during the last 4 weeks? a. your level of sexual desire, b. your ability to 
have an erection, and c. your ability to reach orgasm” on a 1 (very poor to none) to 5 
(very good) scale (Appendix A).      
Additionally, physicians included questions asking about sexual aid use (“Which 
of the following, if any, have you used in the past 4 weeks to improve your erections?” 
offering five options, i.e., medication, penile injection therapy, vacuum erection device, 
MUSE, and the option to write in “other” sex aid), which was scored dichotomously to 
indicate no use or use in the previous month, and confidence in ability to satisfy partner 
(“How would you rate...during the past 4 weeks your ability to satisfy your spouse or 
partner sexually” on a 1 (very poor to none) to 5 (very good) scale). This item was asked 
both with and without using medication, and the highest score was taken to indicate 
greatest confidence (Appendix A).   
Finally, some information about the patient and their treatment characteristics was 
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recorded by the patient’s medical team rather than asked directly of the patient. This 
included patient’s date of birth, type of surgical treatment (i.e., open vs. robotic), and 
degree of nerve-sparing (e.g., none, modified, and bilateral). All open procedures used a 
retropubic abdominal incision, while robotic-assisted procedures used laparoscopic 
abdominal incisions. For the purpose of this study, the degree of nerve sparing was 
determined by the patient’s surgeon and was based on the estimated percentage of nerves 



























 Multilevel modeling procedures (via HLM version 7 software; Raudenbush, Bryk, 
& Congdon, 2011) were used to address study aims, which allowed the examination of 
effects at multiple levels of the data. Specifically, the purpose was to analyze a data 
structure where lower-level time observations (level-1) were nested within men (level-2). 
Models are described using the common terminology for multilevel modeling 
(Raudenbush et al., 2011). HLM utilizes restricted maximum likelihood, which robustly 
handles missing data at level-1 when modeling individual trajectories. Missing data at 
level-2 amounted to less than 5% of the data, and listwise deletion was used to handle 
this. This software program is particularly beneficial in its handling of unbalanced data, 
which in this study included men varying both in their number of time points and the date 
on which they returned each questionnaire packet relative to the target month. For each 
point of follow-up, time was calculated as the number of months since the individual’s 
baseline. A predicted trajectory, with intercept and slope, was then created for each 
individual. Models for both Aims were primarily set up and analyzed the same way, with 
the exception of the addition of five time-varying covariates (TVCs) at level-1 in Aim 2 
(i.e., level of desire, perceived erectile ability, perceived orgasm ability, confidence in 
ability to satisfy one’s partner, and use of sexual aids). In addition to the advantage of 
HLM in simultaneously estimating level-1 and level-2 nested data, it also allows for 








First, study variables were examined in their raw state to obtain descriptive 
information, test for multicollinearity and meeting assumptions of normality, and to 
ensure that a linear model was an appropriate fit for the data, prior to running models. 
Descriptions of data transformations (e.g., centering decisions) are listed below by the 
appropriate Aim. Given that men were allowed to vary in the number of follow-up points 
completed at the time of the study, as well as the exact timing relative to the study targets 
in which they submitted data for each point of follow-up, we examined these patterns in 
our sample. Although participants had to contribute pretreatment data plus three points of 
follow-up at the time of the study in order to be included, most had participated at a 
higher rate (Range: 4-11 time points; M = 7.26, SD = 2.02; Median = 7). The median 
number of days prior to surgery that men supplied pretreatment data was 6, though the 
modal time was the day before surgery. Most men attended their first follow-up 
appointment between 1 and 3 months after surgery, at which time they submitted 
posttreatment baseline data (M = 2.03, SD = 1.45). More participants in the study 
received robotic assisted laparoscopic procedure (62.2%) than an open retropubic one 
(37.7%). Participants also varied in the degree to which the nerves around the prostate 
were spared (i.e., None: 14.4%, Modified/Unilateral: 40.1%, Bilateral: 45.3%). 
Participants in our sample were more likely to have had at least some nerves spared if 
they had a robotic procedure (96%), than if they had an open one (68%), X2(1) = 74.68, 
p<.001. Those variables unique to a given Aim (i.e., pretreatment sexual functioning, 
pretreatment sexual activity, the five TVCs) are described below in the appropriate Aim. 
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Aim 1: Trajectories in Sexual Functioning Recovery 
Preliminary analyses on sexual functioning suggested that, on average, men 
experience a significant decrement from pretreatment (M = 59.23, SD = 24.48) to 
posttreatment baseline (M = 25.18, SD = 20.80), t(498) = 34.94, p<.001. In order to 
examine whether there was sufficient within-individual and between-subjects variance in 
the outcome to test our hypotheses, an unconditional model was run first with no 
predictors (see Appendix B). This model revealed an intraclass correlation coefficient 
(ICC) of .64, indicating that 64% of the total variance in sexual functioning scores after 
surgery was between men. This significant variance component also justified testing both 
level-1 and level-2 predictors, as hypothesized. Next, in order to address the first research 
question for this aim (i.e., Do men vary in their rate of recovery for sexual functioning 
after prostate cancer treatment?), the unconditional random growth model added linear 
time (in months) as the only predictor to determine whether it accounted for variance in 
sexual functioning. Significant variance components were present both on the intercept, 
i.e., men’s initial sexual functioning scores at posttreatment baseline, and on the slope, in 
linear change over time (see results of preliminary analyses in Appendix B). This 
suggests that men differed both in their level of sexual functioning early after surgery, as 
well as in overall rate of improvement over time, or trajectories. Thus, even though 
hypotheses were not offered about differences at baseline, we decided to explore the 
possible factors that might explain this variance by including the same level-2 predictors 
on the intercept as were planned for the slope. The significant slope of the baseline 
model, B = .27, SE = .02, p<.001 (for every 1-month change) suggested that the average 
man improved approximately 3.24 points on the sexual functioning scale each year from 
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baseline (scored 0-100). Further analyses found that linear time accounted for 29% of the 
within-man variance, and that the model was significantly improved by the inclusion of 
the level-1 predictor time, as well as by random effects on the intercept and time. Thus, 
all further models included these.  
Next, to address the second research question (i.e., what between-subjects factors 
account for differences in sexual functioning after surgery), the following hypothesized 
predictors were examined: age, pretreatment sexual functioning, surgery type, and degree 
of nerve-sparing. Initially, each predictor was added independently as the sole level-2 
predictor on the intercept and slope, with time as the level-one predictor. Thus, there 
were four 2-level models, where measures for each time point (level-1 time in months 
variable) was nested within-person (level-2 between-subjects variables).  
In the basic level-1 equation,  
Yti = π0i + π1iɑti + eti 
where π01 = sexual function at posttreatment baseline (ɑti = 0) for person i, π1i = growth 
rate for person i over the data-collection period in months, and represents the expected 
change across months when ɑti = months since posttreatment baseline. 
The level-2 equation for each model introduced a between-subjects factor and 
tested whether it accounted for variance in men’s posttreatment baseline and/or recovery 
rates, e.g., 
π0i = β00 + β01(AGE) + roi 
π1i = β10 + β11(AGE) + r1i 
where for the fixed effects, β00 = mean initial sexual functioning for the average-aged 
man at baseline posttreatment and β10 = mean rate of recovery across men. In this 
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example, age is centered at the grand mean, such that a significant effect on the intercept 
with a negative coefficient would indicate that older men had lower sexual functioning 
scores at baseline posttreatment than younger men, and a significant effect on the slope 
with a negative coefficient would indicate that older men had a slower rate of recovery 
over time than younger men.    
Each model with a separate level-2 predictor revealed significant effects on both 
the intercept and the slope, indicating the appropriateness of including all four predictors 
in the final model. Additionally, interaction terms were initially included in models to test 
for a qualifying relationship of the degree of nerve sparing by surgery type, and then were 
subsequently removed when no effect was present.  
Thus, the final 2-level model was as follows: 
Level 1 
SEXUAL FUNCTIONINGti = π0i + π1i*(TIMEti) + eti  
Level 2 
π0i = β00 + β01(AGE) + β02(PRETREATMENT SEXUAL FUNCTIONING) + 
β03(SURGERY TYPE) + β04(DEGREE NERVE SPARING_1) + β05(DEGREE NERVE 
SPARING_2) + roi 
π1i = β10 + β11(AGE) + β12(PRETREATMENT SEXUAL FUNCTIONING) + 
β13(SURGERY TYPE) + β14(DEGREE NERVE SPARING_1) + β15(DEGREE NERVE 
SPARING_2) + r1i 
where age and pretreatment sexual functioning are grand-centered, surgery type is 
dummy-coded (0 = open and 1 = robotic), degree of nerve sparing_1 is coded 0 = no 
nerve sparing and 1 = modified, and degree of nerve sparing_2 is coded 0 = no nerve 
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sparing and 1 = bilateral nerve sparing).  
Results for the intercept suggested that the average posttreatment baseline level of 
sexual functioning after surgery was 10.98 for men of average age, who received open 
surgery, no nerve sparing, and with average pretreatment sexual functioning. For the 
intercept, there were significant main effects of age, degree of nerve sparing, and 
pretreatment sexual functioning (see Table 2 for all results). Of the level-2 fixed effects, 
the degree of nerve sparing had the greatest impact on baseline postsurgery sexual 
functioning, particularly for those who had bilateral nerve-sparing procedures (B = 18.61, 
SE = 2.22, p<.001). Indeed, post hoc analyses indicated a significant difference between 
modified and bilateral nerve sparing, with bilateral nerve-sparing procedures resulting in 
a higher baseline posttreatment level of sexual functioning (Estimate = 7.54, SE = 1.92), 
χ2 (1) = 1.95, p < .001. As hypothesized, there was a significant fixed effect of 
pretreatment sexual functioning on the slope, which is illustrated in Figure 1. Post-hoc 
simple slopes indicated effects of pretreatment sexual functioning on posttreatment rates 
of recovery over time for men with both high pretreatment functioning (Estimate = 0.53, 
SE = 0.14), χ2(1) = 15.29, p<.001), and low pretreatment functioning (Estimate = 0.33, 
SE = 0.13), χ2(1) = 6.24, p<.05). It was also hypothesized that age, degree of nerve 
sparing, and surgery type would vary between men, which would influence their sexual 
functioning recovery rates; however, this was not supported in our models.  
Thus, overall, Aim 1 results suggested that men differed in their levels of sexual 
functioning after treatment, as measured by the EPIC questionnaire, both in terms of 
levels early after surgery and in their rates of recovery over time. Younger men who 
received any amount of nerve sparing and who had higher pretreatment sexual 
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functioning, started higher than other men at postsurgery baseline. Bilateral nerve sparing 
had the most significant impact on levels of sexual functioning at baseline after surgery. 
From that early level of posttreatment functioning, there was improvement over time for 
most men, but the rate of that improvement depended on pretreatment sexual functioning, 
with higher functioning men experiencing a faster rate of recovery over time. In other 
words, having higher pretreatment sexual functioning resulted in men both starting off 
higher postsurgery and increasing faster over time. 
 
Aim 2: Factors That Influence Men’s Frequency of Sexual Activity 
 
 Descriptives for the scale-type TVCs and Aim 2 outcome are listed in Table 1, 
including means, standard deviations, and frequencies at pretreatment and baseline 
posttreatment. For the dichotomous TVC, sexual aids, more men reported use in the early 
period after surgery (63.7%) than endorsed them prior to surgery (16.1%; χ2 (1) = 12.67, 
p < .001). Of the men who noted erectile aid use prior to surgery or early after surgery, 
medication (i.e., PDE-5 inhibitors, such as Viagra) was by far the most common, with 
less than 10% of men endorsing any other option (e.g., at baseline postsurgery: 
medication 96.5%, penile injection therapy 2.5%, 0.3% vacuum erection device, and 
other 0.6%). Preliminary analyses suggested that, on average, men experienced a 
significant decrease in rates of sexual activity from before surgery (M = 2.67, SD = 1.06) 
to the early period (i.e., first few months) after surgery (M = 2.03, SD = 1.05), t(498) = 
34.94, p<.001. Notably, even if there was a decrease in frequency compared to before 
surgery, over half (57.6%) of men at baseline posttreatment endorsed at least some sexual 
activity in the previous month.  
In order to determine the appropriateness of testing research question one and two 
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(i.e., whether there were within-person and between-men differences in the frequency of 
sexual activity after surgery), unconditional models first tested for variance components 
(see Appendix B). Results of the unconditional baseline model suggested significant 
variance within- and between-men in frequency of sexual activity (ICC: .59), which 
justified testing both level-1 and level-2 predictors. The unconditional random growth 
model further found significant variance components both on the intercept (men’s initial 
frequency of sexual activity posttreatment) and on the slope (linear change over time). 
Thus, similar to Aim 1, we included the same level-2 predictors on the intercept as were 
planned for the slope. For the slope in the unconditional growth model, the coefficient 
was quite small (B= .001 average monthly increase, SE = .04, p<.001), suggesting that 
the average man would have to wait several years to experience much meaningful change 
solely from time, without considering other contributors (e.g., TVCs). Additional 
analyses demonstrated that 12% of the within-person variation over time in the frequency 
of sexual activity was explained by linear time.  
Next, a series of models tested the five level-1 within-person TVCs of interest 
(i.e., confidence in ability to satisfy partner, sexual desire, perceived erectile ability, 
perceived orgasm ability, and use of sexual aids) to determine their appropriateness for 
inclusion in the final model. Initially, these models separately examined the effects of 
each TVC, including each of their relationships with time and their unique contribution. 
Including time separately in each model allowed an examination of whether there was a 
distinct effect of linear time on sexual activity (i.e., if improvement is steady and directly 
due to their temporal distance from the surgery date) or whether the within-men effect 
may have been fully accounted for by the monthly association between the TVCs and the 
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outcome. In all growth models, random effects for the intercept and time, but not for the 
TVCs, were included. Also, in all growth models with TVCs, sexual aids was dummy 
coded 0 = no use, 1 = use. The remaining four TVCs were detrended (i.e., removing any 
linear growth over time) in SPSS software prior to their inclusion in models, as is the 
current recommendation for the use of TVCs in linear growth models (Curran & Bower, 
2011). Detrending is a type of data transformation appropriate in longitudinal analyses 
with TVCs when person-centering is desired but growth in the TVC over time would 
violate those assumptions. The following describes an example of these preliminary 
analyses, where for the level-1 equation:    
SEXUAL ACTIVITYti = π0i + π1iɑti + π2i(ERECTILE ABILITY) + π3iɑti(ERECTILE 
ABILITY) + eti 
where π01 = frequency of sexual activity at posttreatment baseline (ɑti = 0) for person i at 
his average level of erectile ability, π1i = rate of sexual activity for person i over the data-
collection period, and represents the expected change across months when ɑti(time) = 
months since treatment, π2i = expected monthly change in rate of sexual activity for 
person i as he deviates from his average levels of erectile ability, and π3i = expected 
change across months as qualified by the monthly association between erectile ability and 
time.  
In these models, all five TVCs were found to significantly relate to frequency of 
sexual activity on a monthly basis, such that on months when a given TVC deviated from 
an individual’s overall average level of that TVC, there was a corresponding change in 
frequency of sexual activity in the same direction (e.g., as a man’s level of desire 
increased from his own average desire in a given month, his frequency of sexual activity 
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also increased during that same month). None of the TVCs interacted with time. Thus, 
time and all five TVCs were included in the final level-1 model. 
In preparing the level-2 portion of the model, we first tested separate models with 
each of the four between-subjects factors on the intercept and on the slope as was 
discussed in Aim 1. The only differences between these models and those in Aim 1 were 
the outcome (i.e., frequency of sexual activity vs. sexual functioning) and the predictor 
measuring pretreatment levels of the outcome (i.e., pretreatment sexual activity vs. 
pretreatment sexual functioning). For all level-2 analyses, the four predictors were 
centered as listed above in Aim 1 (e.g., pretreatment sexual activity was grand-centered). 
Each of these four models showed a significant effect of the predictor on the intercept 
(i.e., men’s level of sexual activity at baseline postsurgery), and thus were all included in 
the final model. None individually had an effect on the slope, but were included in the 
final model in case adding in the five TVCs at level-1 would influence the effect of the 
level-2 predictors on the slope. Additionally, interaction terms were initially included in 
models to test for a qualifying relationship of the degree of nerve sparing by surgery type, 
and then were subsequently removed when no effect was present.  
 The final model was as follows: 
Level 1 
SEXUAL ACTIVITYti = π0i + π1i*(TIMEti) + π2i*(DESIREti) + π3i*(ERECTILE ABILITYti) 
+ π4i*(ORGASM ABILITYti) + π5i*(SATISFY PARTNERti) + π6i*(SEXUAL AIDSti) + eti  
Level 2 
π0i = β00 + β01(AGE) + β02(PRETREATMENT SEXUAL ACTIVITY) + 
β03(SURGERY TYPE) + β04(DEGREE NERVE SPARING_1) + β05(DEGREE NERVE 
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SPARING_ 2) + roi 
π1i = β10 + β11(AGE) + β12(PRETREATMENT SEXUAL ACTIVITY) + 
β13(SURGERY TYPE) + β14(DEGREE NERVE SPARING_1) + β15(DEGREE NERVE 
SPARING_ 2) + r1i  
For Research Question 1, it was hypothesized that variations across men in the 
trajectory of sexual activity frequency over time would be influenced by the same factors 
as identified to be relevant in sexual functioning research (i.e., age, pretreatment sexual 
activity, type of surgical approach, and degree of nerve sparing), such that younger men 
with greater pretreatment sexual activity who received robotic surgery with a greater 
degree of nerve sparing would be expected to have a steeper slope in their trajectory. 
However, none of the predictors were significant on the slope (rate of change across 
time), indicating that these variables did not influence the trajectory of men’s rate of 
sexual activity across time. Although a priori hypotheses were not offered related to the 
intercept, our analyses indicated that age (B = -.02, SE = .005, p < .001), pretreatment 
sexual activity (B = .43, SE = .04, p<.001), and nerve sparing (for both: B = .38, .10, 
p<.001) were all significantly associated with baseline posttreatment sexual activity (see 
Table 2). This indicates that these variables were associated with men’s frequency of 
sexual activity in the first couple of months after surgery, rather than the rate of change in 
activity across time. There was not a significant difference between unilateral and 
bilateral nerve sparing, χ2 (1) = 0.30, p >.500. Given the coefficient of the intercept (B = 
1.96 for the average aged man with average pretreatment sexual activity who had open 
surgery with no nerve sparing at time = 0, who was at his average for TVCs), results 
indicated that on average, those who had at least some degree of nerve sparing, a one-
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point increase over average levels of pretreatment sexual activity, and were 6 years 
younger than average (i.e., 1 SD) had a score of 2.89, or almost a full one-unit increase on 
a 5-point scale in frequency of sexual activity that month.  
For Research Question 2, it was hypothesized that the within-person monthly 
variation of the TVCs (e.g., erectile ability) would be associated with a similar monthly 
change in the frequency of sexual activity. Indeed, each of the TVCs were significant in 
the final model, suggesting that on those months when a given man used sexual aids 
and/or had a 1-unit increase above his average levels of desire, confidence in satisfying 
his partner, perceived orgasm ability, and/or perceived erectile ability, he had a 
corresponding increase in frequency of sexual activity (see Table 2 for all model 
coefficients and standard errors and Figure 3 for an example of the association between a 
TVC and frequency of sexual activity). The scaled TVC with the highest regression 
coefficient was perception of orgasm ability (B = .22). Further, the slope of time in 
months was significant, suggesting that in addition to the monthly varying association 
between the TVCs and sexual activity, there was a steady, slight improvement over time 
in men’s frequency of sexual activity (see Figure 2).  
Taken together, the results of the analyses in Aim 2 suggested a complex pattern 
regarding the frequency of sexual activity after prostatectomy. It appears that men did not 
greatly improve over time in their frequency of sexual activity, regardless of their 
treatment characteristics, age, or pretreatment sexual activity. Rather, men differed from 
each other in their initial levels of sexual activity after treatment, and this benefitted 
younger men, those with greater frequencies of pretreatment sexual activity, and those 
with greater degrees of nerve sparing. By including the five varying factors (e.g., desire) 
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that were measured at the same points as the outcome, we learned that much of the 
within-individual variation in frequency of sexual activity across time was related to 
corresponding fluctuations in those factors (TVCs). In other words, those factors and the 
frequency of sexual activity tended to fluctuate from month-to-month together around a 
man’s average. Thus, there were between-group differences in baseline levels of sexual 
activity after surgery, and then from month-to-month individual men varied around their 
own average levels of sexual activity depending on changes in desire, confidence in 
satisfying a partner, perceived erectile ability, perceived orgasm ability, and whether or 












































 Pretreatment Baseline Answer Choice 1 Answer Choice 2 
       Pre Post Pre Post 
 M(SD) N M(SD) N N(%) N(%) N(%) N(%) 
Sexual 
Activity 
2.67(1.06) 522 2.03(1.05) 524 90(17.2) 222(42.4) 130(4.9) 119(22.7) 
Desire 3.48(1.45) 520 2.86(1.21) 522 35(6.7) 91(17.4) 68(13.1) 114(21.8) 
Erectile 
Ability 
3.53(1.24) 511 1.60(.96) 517 42(8.2) 332(64.2) 71(13.9) 106(20.5) 
Orgasm 
Ability 
3.82(1.20) 508 2.19(1.32) 511 35(6.9) 233(46.2) 41(8.1) 76(14.9) 
Satisfy 
Partner 
3.66(1.31) 509 2.00(1.32) 502 57(11.2) 283(56.4) 44(8.6) 60(12.0) 
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Table 1 Continued 
 Answer Choice 3 Answer Choice 4 Answer Choice 5 
  Pre Pre Post Post Pre Post 
 N(%) N(%) N(%) N(%) N(%) N(%) 
Sexual 
Activity 
174(33.3) 130(24.8) 120(23.0) 50(9.5) 8(1.5) 3(0.6) 
Desire 136(26.2) 130(24.9) 176(33.8) 151(28.9) 105(20.2) 36(6.9) 
Erectile 
Ability 
107(20.9) 42(8.1) 158(30.9) 29(5.6) 133(26) 8(1.5) 
Orgasm 
Ability 
87(17.1) 95(18.6) 162(31.9) 73(14.3) 183(36) 31(6.1) 
Satisfy 
Partner 
77(15.1) 64(12.7) 170(33.4) 65(12.9) 161(31.6) 30(6.0) 
Note. All scale variables were scored 1-5, with higher values indicating higher levels of the 
measured variables. See Appendix A for labels. For each variable, most frequent response 
for pretreatment in bold type and posttreatment underlined. “Baseline” refers to baseline 





















For INTERCEPT, π0	 B(SE)	 	 B(SE)	 	
Intercept, β00 10.97(2.05)***  1.96(.17)*** 
Surgery Type, β01 3.23(1.83)  -0.11(.18) 
Age, β02 -0.28(.14)*  -0.02(.005)*** 
Degree Nerve Sparing 1, β03  11.07(1.93)***  0.38(.10)*** 
 Degree Nerve Sparing 2, β04 18.61(2.21)***  0.38(.11)*** 
Pre-Trtmt Sexual Functioning1/Activity2, β05 0.32(.03)***  0.42(.04)*** 
For TIME (MONTHS) slope, π1    
Intercept, β10 0.32(.07)***  0.003(.001)* 
Surgery Type, β11 -0.10(.05)  0.004 (.008) 
Age, β12 -0.004(.004)  0.000(.0000) 
Degree Nerve Sparing 1, β13 -0.04(.06)  0.004(.007) 
Degree Nerve Sparing 1, β14 -0.01(.07)  0.007(.008) 
Pre-Trtmt Sexual Functioning1/Activity2, β15 0.004(.001)**  0.001(.001) 
For ERECTILE AIDS slope, π2    
Intercept, β20 NA  0.20(.14)*** 
For DESIRE slope, π3    
Intercept, β30 NA  0.15(.21)*** 
For SATISFY PARTNER slope, π4  	 	











 Aim 2 
Sexual Activity 
For ERECTILE ABILITY slope, π5	  	 	
Intercept, β50 NA  0.11(.04)** 
For ORGASM ABILITY 
slope, π6	
 	 	
Intercept, β60 NA  0.23(.04)*** 
















































Figure 1. The effect of the Aim 1 interaction between time, in months since baseline, and 
pretreatment sexual functioning, grand-centered, on sexual functioning scores. The z-axis 
depicts pretreatment sexual functioning at the grand mean (PTSF_GC, red line) and at 
two levels found to be significant in post-hoc analyses: at one standard deviation above 
the grand mean (PTSF +1SD, green line), and at 1 standard deviation below the grand 
mean (PTSF -1SD, blue line). Those with higher pretreatment sexual functioning have 
steeper trajectories than men with average pretreatment sexual functioning, and those 
with lower pretreatment sexual functioning have flatter trajectories than men with 
average pretreatment sexual functioning.   
 
 




























Figure 2. The pattern of the Aim 2 outcome (frequency of sexual activity) across time in 
months after surgery when the outcome is centered at the individual’s mean, such that 
each gray line illustrates a man’s variations around his average across time and the black 
dashed-dotted line represents the best fit linear trend, demonstrating the significant, yet 











Figure 3. The association of within-person ratings (on five-point scales) between one of 
the five time-varying covariates (i.e., Perception of Orgasm Ability) and the Aim 2 
outcome (Frequency of Sexual Activity) when such ratings are centered at the 
individual’s average. Positive values on both axes (i.e., a dot in the upper right quadrant) 
suggest a month when a man was both above his average level of orgasm ability and 
above his average frequency of sexual activity. The blue line indicates the best fit linear 
relationship between ratings of orgasm ability and sexual activity within-men, and is 












This study examined sexual quality of life outcomes after surgical treatment of 
prostate cancer utilizing several  novel methodological approaches, including (1) the use 
of statistical approaches that account for dependence in nested data structures, (2) a more 
thorough examination of the influence of time on the outcome through longitudinal 
analyses, and (3) proposing the value of a more specific construct, sexual activity, in 
order to increase the clinical utility of the research in this area. The potential value and 
implications of this study are thus both methodological and clinical, and are discussed 
separately. 
 
Methodological Improvements in Examining Sexual Quality of Life 
 
Previous research has approached the examination of sexual quality of life after 
prostate cancer by comparing broad sexual functioning immediately following prostate 
cancer surgery with some point in time in the recovery process. This existing work has 
been valuable in identifying factors (e.g., patient age) that appear to relate to postsurgery 
quality of life, and in demonstrating that many men do experience some degree of change 
in their sexual functioning after surgery. The challenge has been in identifying, with 
cross-study consistency, the specific influence of individual difference variables while 
simultaneously capturing the unique degree of improvement, if any, from natural 
recovery across time. In other words, we have thus far been unable to provide men or 




recovery they might experience, and what might improve or worsen those odds. 
Multilevel linear growth modeling allows us to observe the intra- and interindividual 
pattern of change, improving the accuracy of our results and isolating unique 
contributions of predictors. Particularly, the ability to parse effects due to variables that 
change over time (i.e., time-varying covariates) from effects that distinguish between 
individuals should provide a more complete picture of men’s experiences after surgery. 
By using linear growth modeling techniques, it is theoretically possible to more 
accurately estimate a man’s expected long-term sexual quality of life given enough 
pretreatment and posttreatment data. Using such an approach for this study, we were able 
to use data on men’s demographics and pretreatment functioning/frequency of sexual 
activity, baseline posttreatment functioning/sexual activity, and multiple points of follow-
up to estimate the expected rate of change for a given man, as well as the unique 
influence of individual difference variables on groups of men. 
Of particular value to our understanding of the long-term period after surgery, using 
linear growth modeling allowed for a more thorough examination of the effects of time, 
which are often masked in typical methodological approaches in this area (e.g., pretest vs. 
posttest). This study was able to identify influences of time on the outcomes in numerous 
ways. We captured a pattern of natural recovery (e.g., the natural healing process) by 
including a main effect of change over time for each man, while simultaneously 
controlling for the effects of other predictors. The use of trajectories in a multilevel 
model allowed us to separately track the patterns of any observed change within-men and 
between-men, in order to investigate the effects on the outcome of predictors as a 
function of time. We were also able to identify individual differences in levels of sexual 
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functioning within the first few months after surgery based on pretreatment and surgery 
characteristics. This suggested that these factors (e.g., greater degree of nerve sparing) 
either encouraged rapid recovery immediately after surgery or protected in some way 
against greater surgery-related loss of functioning. Further, with the ability to separate out 
the between-men predictors on both initial status (baseline postsurgery) and rate of 
change over time, we identified a particularly strong influence of pretreatment sexual 
functioning on functioning after surgery: men with higher pretreatment sexual 
functioning both started with higher functioning after surgery and improved faster than 
those with lower pretreatment functioning. Finally, by including predictors with time at 
level one in Aim 2 models with sexual activity as the outcome, we could identify monthly 
associations between time-varying factors (e.g., levels desire) and the frequency of sexual 
activity to illustrate that deviations from an individual man’s average level of these 
factors in a given month resulted in similar changes in the outcome during that same 
month.  
 
Comparisons With the Existing Sexual Functioning Literature 
 
In order to compare our findings with those reported in the existing literature, we 
first examined the most commonly used outcome construct: broadly measured sexual 
functioning. We were able to replicate previous findings and provide clarification for 
effects that appear inconsistent throughout the literature. For example, similar to others 
(Moskovic et al., 2011; Rabbani et al., 2000), our findings supported that younger men 
have better sexual functioning after surgery than older men, but the effect was found at 
baseline after surgery rather than on the rate at which men recover over time. This may 
suggest that any benefit from younger age occurs very early on, such as influencing the 
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speed at which men physically recover in the first few months before their first follow-up 
appointment (i.e., our first measurement occasion). Alternatively, instead of indicating 
greater early recovery, it may actually be that younger men experience less decrements to 
functioning from surgery. Parsing this effect would require a closer examination of the 
period in the first few months after surgery.  
Next, the effect of surgery type on broad sexual functioning has been inconsistent in 
the literature, particularly in whether the introduction of robotic technology has had a 
positive impact on sexual functioning due to increased precision (e.g., Menon et al., 
2007). Our findings indicated that there is no unique effect of surgery type on initial 
postsurgery levels of sexual functioning or on rate of improvement over time. Rather, it is 
likely that any effect of surgery type is being captured by nerve sparing, which was 
highly impactful on men’s initial levels of sexual functioning after surgery, particularly if 
they received bilateral nerve-sparing. The preservation of nerves likely lessens the 
damage to smooth muscles and nerves needed for erectile capacity (Chung & Brock, 
2013), which may have resulted in less negative impact of surgery on sexual functioning 
scores. Although a robotic procedure may in fact result in less overall tissue damage than 
open procedures, perhaps the nerve bundles are the most important parts of the tissue in 
the area surrounding the prostate for erectile capacity. Our findings also suggest that 
nerve sparing does not directly influence rates of recovery of functioning over time, 
further supporting that men with greater nerve preservation may retain more of their 
pretreatment sexual functioning after surgery than other men.  
We also found that men with higher pretreatment sexual functioning recovered their 
sexual functioning at a faster rate over time than did men with lower pretreatment sexual 
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functioning. Lower pretreatment sexual functioning could be the result of non-cancer-
related contributors, such as heart disease or diabetes (Turek et al., 2013). While 
treatment can stop the spread of the cancer, it is unlikely to restore losses to sexual 
functioning that were already present, which may be why these men experience lower 
rates of recovery over time. Thus, even though we did not follow men for the rest of their 
lives, our models indicate that that those younger men with higher pretreatment sexual 
functioning scores who were candidates for nerve-sparing procedures will enjoy the 
highest levels of broadly measured sexual functioning scores at all points in time after 
surgery compared to other men with prostate cancer.   
 
Introducing an Alternative Construct 
 
The final methodological approach used in this study was to examine a different 
construct than in previous work: frequency of sexual activity. Using the same 
methodologically advantageous approach as in our analyses on sexual functioning, we 
investigated men’s frequencies of sexual activity after surgery. We examined the same 
individual difference variables as we did in sexual functioning analyses (i.e., age, degree 
of nerve-sparing, surgery type, and pretreatment sexual activity), and found similar 
effects on the frequency of sexual activity (Aim 2) at baseline postsurgery as in our 
earlier sexual functioning analyses (Aim 1). For example, younger men engaged in more 
frequent sexual activity in the first several months after surgery than did older men. 
Further, there was no effect of surgery type on baseline frequency of sexual activity or on 
trajectories. There was an effect of nerve sparing on baseline postsurgery rates of sexual 
activity, but unlike in earlier sexual functioning analyses, we observed no greater rates in 




Finally, even though most men’s rates of sexual activity decreased from 
pretreatment to baseline postsurgery, those with higher presurgery rates also evidenced 
higher postsurgery rates of sexual activity. Perhaps those couples who were used to more 
frequent sexual activity sought it out again early after surgery as a way to maintain 
intimacy, even if it was not the identical experience as before surgery. This would be 
similar to findings on the effect of other life challenges on sexual activity, like pregnancy 
(Leeman et al., 2012). Unlike in our sexual functioning analyses, pretreatment sexual 
activity did not influence men’s trajectories of sexual activity over time. In fact, we did 
not find any effect of individual difference variables on growth trajectories. 
Arguably, the most clinically and methodologically valuable information gained 
from using frequency of sexual activity as an outcome, as opposed to sexual functioning 
scores, was our finding that monthly rates of sexual activity varied as a function of its 
associations with one’s level of desire, perception of erectile ability, confidence in ability 
to satisfy partner, perception of orgasm ability, and use of sexual aids, such as PDE-5 
inhibitors. This illustrated that the frequency with which couples engage in sexual 
activity after surgical treatment of prostate cancer is fluid and dynamic. In other words, 
we demonstrated that unlike the pattern of sexual functioning scores after surgery, the 
frequency of sexual activity is more variable from month-to-month and depends on a 
man’s current attitudes and predictions about how the sexual experience might go were 
he to engage in it.  
These findings offer a number of clinical implications, which are elaborated upon 
in the next section. From a methodological perspective, though, our results suggest that 
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researchers in this area may want to consider the use of more sophisticated statistical 
techniques in their longitudinal studies and more clinically useful constructs, like the 
frequency of sexual activity, in order to gain new, valuable insights into men’s sexual 
quality of life. This is not to say that there is not value in using broad constructs, like 
sexual functioning, as an outcome. Rather, the choice of construct depends on the 
questions one hopes to answer, and by using advanced statistical methods, we gain 




 The findings in this study provide potentially valuable clinical information to 
medical providers and their patients as they make a treatment decision and search for 
ways to improve patients’ sexual quality of life after surgery. The current literature 
suggests that most couples strongly want to be sexually intimate after surgery, and thus 
are seeking guidance and reassurance (Chung & Brock, 2013). Unfortunately, it has been 
challenging to accurately prepare couples for what to expect and to reassure them that 
there is hope in returning to an active sex life. These results provide important insights 
into men’s experiences of sexual activity after prostate cancer, something that is not 
typically addressed in this body of research. Even though we cannot translate our scale-
type measure into an exact count of sexual encounters, we can confidently say that, on 
average, most men reported some monthly sexual activity across time. Many couples are 
engaging in some type of sexual activity within a few months after surgery (57.6%). Of 
course, given the impact of the within-men and between-men factors, there were 
variations observed, and in this information lies much of the clinical utility of these 
findings. There are several ways providers could use these findings to help their patients 
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navigate the cancer survivorship process, such as fostering realistic expectations of what 
to expect and when to seek help, encouraging couples to shift their focus to a broader 
conceptualization of sexuality and sexual satisfaction, and targeting the five influencing 
factors found to vary from month-to-month in order to optimize the frequency of sexual 
activity.  
 
Setting Realistic Expectations 
 
The findings on sexual activity in this study, combined with other sex research, 
could be used prior to surgery to provide couples with information that encourages 
realistic expectations. For example, they can be informed that levels of sexual activity 
after surgery will be variable depending on multiple factors (e.g., level of desire) rather 
than just depending on their erectile capacity, which was also variable. Additionally, one 
study found that if men maintained the unrealistic expectation that they would completely 
regain their pretreatment erectile capacity, they were more likely to have poorer 
emotional outcomes (Katz, 2015). Thus, in addition to instilling hope with findings from 
this study, it would be important to also inform patients that they may never return to 
their pretreatment erectile capacity.  
They can also be provided with individually tailored expectations for their 
frequency of sexual activity in the first few months after treatment based on the man’s 
age, the likelihood of nerve preservation in his surgery, and the couple’s previous pattern 
of sexual activity. Although they should expect a decrease in the frequency immediately 
following surgery, rates did not go to zero after surgery for most patients. Instead, many 
men who engaged in a relatively higher frequency of sexual activity prior to treatment 
still reported sexual activity immediately following surgery, just at a lower frequency 
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than they had prior to surgery. For all men, there was a slight increase in sexual activity 
over time as they recovered from surgery. The better predictor of increased sexual 
activity, though, was the month-by-month levels of desire, perceived orgasm ability, 
confidence in satisfying one’s partner, perceived erectile capacity, and the use of erectile 
aids. This is encouraging because these are factors that fluctuated over time and can be 
targeted in clinical interventions. Therefore, sexual activity posttreatment is much more 
fluid than perhaps originally thought, and men (and their partners) can take an active role 
in increasing their levels of sexual activity. 
Having an open conversation with their provider about what to expect after 
surgery might serve to increase couples’ comfort with bringing up sexual concerns after 
surgery. Research has found that patients tend not to bring up sexual issues with medical 
providers unless that provider has appeared open and willing to discuss them (Wittmann 
et al., 2009), and that patients often feel there are no options when sexual issues present 
after surgical treatment of prostate cancer (Walker & Robinson, 2011). This approach to 
setting realistic expectations might serve to increase patients’ perceptions of having made 
an informed treatment decision, protect against postsurgery surprise and disappointment, 
and encourage the couple to bring up sexual issues after treatment (Paisch et al., 2016).  
 
Shifting to a Broader Conceptualization of Sex 
 
Discussion in the literature has proliferated in recent years about the need to 
identify interventions that could be used to improve sexual quality of life after prostate 
surgery, particularly targeting couples’ sexual intimacy and sexual satisfaction (see 
Chung & Brock, 2013; Wittmann et al., 2015). With the goal of understanding more 
about couples’ sexual encounters after surgery, this study focused on measuring sexual 
48 
 
activity defined broadly, rather than being limited to only intercourse. Findings 
highlighted that even if they are not able to engage in intercourse, most couples continue 
to be engaged in some type of sexual activity across time. Although this study did not 
identify the specific sexual behaviors in which couples engaged, their endorsement of the 
item indicates that they perceived the behaviors to be sexual in nature. Sex researchers 
have posited that the ways in which individuals conceptualize constructs like “having 
sex” and “sexual activity” might influence how well they adapt to a change in functioning 
that impacts their ability to engage in certain sexual behaviors, like intercourse (e.g., 
Sewell & Strassberg, 2015).  
Within the field of prostate cancer research, some have called for finding ways to 
help couples increase satisfaction within their current sexual capabilities when there are 
unlikely to be additional improvements in erectile capacity (Galbraith et al., 2011; Reese 
et al., 2010). To that end, interventions are needed to help couples shift to a less 
intercourse-focused view of sexuality, such that their emphasis is on maintaining sexual 
intimacy even in the absence of significant erectile ability. Indeed, some heterosexual 
couples have reportedly come to appreciate the value in broadening their sexual 
experiences after surgery because of the increased focus on activities more stimulating to 
the female partner (see Katz, 2015). Further, a related study examining men with prostate 
cancer on androgen deprivation therapy (ADT) found that couples who expanded their 
view of sexual satisfaction to include nonintercourse behaviors were better able to cope 
with symptoms (Hamilton et al., 2015). Thus, interventions in this area might have two 
components: psychoeducation to teach the couple about alternative ways to express their 
sexuality, and cognitive approaches to increase sexual flexibility and challenge rigid 
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thinking patterns (Reese et al., 2010).  
 
Exploring New Interventions 
 
Findings in this study of five factors that are related to monthly sexual activity 
may guide clinicians and researchers in efficacious interventions. In addition to helping 
couples set realistic expectations and shift their focus to a broader set of sexual behaviors 
and experiences, clinicians can directly target those five factors in order to help couples 
increase the frequency with which they are engaging in sexual behaviors. Since several of 
those factors measure cognitions (i.e., perceptions about orgasm and erectile ability; 
confidence in ability to satisfy partner), interventions might focus on helping couples 
process their appraisals of physical changes and self-image, reframe perceptions of 
“failed” sexual experiences more accurately and positively, and set up positive 
expectations for the future (Brock & Chung, 2013).   
The couple might also benefit from exploring ways of expressing sexual intimacy 
that increase their pleasure and satisfaction during sexual encounters, which may increase 
the likelihood of having an orgasm. Research shows that although most men experience 
orgasm and ejaculation as paired, neither the postsurgery loss of ejaculatory fluid nor 
impaired erectile capacity necessarily precludes orgasm ability (Koeman et al., 1996). 
Given our finding of the strong influence of perceived orgasm ability on the frequency of 
sexual activity, helping couples in their efforts to reach orgasm despite incomplete 
erectile capacity should be highly beneficial to their level of satisfaction. Sex therapy 
techniques might be utilized that have been shown to be effective, such as sensate focus 
(Wincze, 2015). Also, existing research indicates that pelvic floor training (e.g., kegel 
exercises) can help increase orgasm strength (see Chung & Brock, 2013).  
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Finally, couples can be encouraged to increase engagement in nonintercourse 
sexual behaviors that are linked to orgasm, such as manual-genital stimulation and oral-
genital stimulation. Since women rarely report PVI as their most sexually pleasurable 
behavior due to the greatest concentration of nerve-endings in the genitals being external 
(e.g., clitoris) and near the entrance of the vaginal canal (Hite, 2004), encouraging 
heterosexual couples to focus on other sexual behaviors might increase her likelihood to 
orgasm and her overall sexual satisfaction. Furthermore, engaging in other pleasurable 
behaviors may increase the man’s perceived ability to satisfy his partner, which can 
increase relationship satisfaction (Yoo, Bartle-Haring, Day, & Gangamma, 2014) and, as 
we found, the couple’s frequency of sexual activity.  
There are interventions that have shown some efficacy in improving men’s 
erectile abilities, such as sexual aids. The most common aids used by our sample included 
PDE-5 inhibitors (e.g., Viagra), vacuum erection devices, and penile injection therapy. 
Previous research finds that some couples are disappointed with erectile aids, mainly due 
to insufficient training, suggesting that psychoeduation may help couples increase their 
willingness and effectiveness with these aids (Walker et al., 2015).  Particularly, Walker, 
Wassersug, and Robinson (2015) suggested that early dissatisfaction with erectile aids 
resulted in discontinuation and reluctance to consider future interventions. On the other 
hand, studies on the use of erectile aids has also found a relationship with increased 
frequency of sexual activity (Lee, Nazroo, & Pendleton, 2015). Towards that end, the 
findings in this study were promising: On the months that our sample used aids, they 
engaged in more sexual activity than on months they did not use them. We are unable to 
say whether they found the sexual activity with aids to be more or less satisfying than 
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without, but research in other areas indicates that erectile aids can also be used to enhance 
couples’ sexual satisfaction and even their orgasm ability (Paduch, Bolyakov, Polzer, & 
Watts, 2013).  
Finally, engaging in sexual activity within the first few months after surgery 
might confer additional benefits to couples who hope to return to presurgery rates of 
sexual activity. It could help them manage disappointment and begin the process of 
adjustment at a time when they have the lowest expectations about erectile capacity. 
Next, research suggests a potential bidirectional relationship between desire and sexual 
activity, such that engaging in sexual activity may result in increased desire through 
increased testosterone, influencing future sexual activity (e.g., Dabbs & Mohammed, 
1992). Thus, if low desire is a problem, encouraging the couple to engage in sexual 
activity anyway might serve as an effective intervention. Finally, providers might 
encourage couples to specifically use sexual activity during the period early after surgery 
as a time to focus on the intimacy gained from touching, kissing, and communicating, 
without the expectation of optimal erectile and orgasmic functioning. Research suggests 
that these types of physical affection can release oxytocin and dopamine, which can be 
self-reinforcing for future sexual activity and increased perceptions of intimacy (Veening 
et al., 2015).  
Thus, there are many factors that can be targeted through clinical interventions in 
order to help couples recover their sexual activity after prostate cancer treatment. In all of 
these, the intervention is likely to be more successful if it includes the partner (e.g., 
Hamilton et al., 2015; Katz, 2015; Nelson et al., 2015). Not only will this allow for a 
focus on building intimacy and enhancing sexual communication, but the dyad may also 
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be more engaged in the treatment if approached jointly and considered “our” problem. 
Research suggests that men may be more open to treatment for sexual problems after 
prostate cancer if a partner is involved (e.g., Chung & Brock, 2013). Further, 
interventions that target couples encourage dyadic coping, or approaching a problem as a 
shared experience to manage, which can allow for additional support, greater availability 
of resources, and better application of the skills (Berg, Wiebe, & Butner, 2008; 
Bodenmann, 2005).  
 
Limitations and Future Directions 
 
As with any study, there were several limitations that may affect the 
generalizability and application of these findings. First, our sample was relatively 
homogenous, with the majority of participants being Caucasian, well-educated, and likely 
higher SES. Although participants were not asked the gender of their partner(s), it is 
likely that most patients were heterosexual. Participants were also slightly younger than 
average for those with prostate cancer (i.e., 60.81 vs. mid- to upper-60s in most studies, 
Glass et al., 2013). Thus, our sample may have had greater access to resources, such as 
sexual aids, and fewer other health-related changes to erectile capacity than typical men 
with prostate cancer. Next, this study did not have access to the partners of the men 
surveyed. We cannot hope to fully understand these couples’ experiences without having 
information from the partner. Since we did not have that data or measures of relationship 
quality, it is unclear how the relationship or the partner’s functioning might have 
influenced frequency of sexual activity. Research suggests that there is often congruence 
in a couple’s sexual functioning, such that when a man reports ED his partner often also 
reports sexual dysfunction (Shindel et al., 2005). It would be most beneficial for future 
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studies to measure and address sexual and relationship issues in both individuals, 
although it is acknowledged how difficult such research can be to conduct.  
Further, there were limits to our measurement of sexual activity that could be 
expanded on in future studies. The scale used to measure the frequency of sexual activity 
was retrospective, queried only the patient, and did not allow for us to identify 
specifically how many episodes of sexual activity in which couples were engaging, or the 
nature of that activity. A more specific weekly diary, completed by both the man and his 
partner, would have been preferable. Particularly if this had been conducted online, 
where reminders could be sent easily, it might have reduced the inconsistent timing 
across participants of returning questionnaires. Future studies might also explore the 
couples’ satisfaction with the specific sexual behaviors in which they engaged so as to 
better inform interventions. Finally, future research might examine the effectiveness of 
interventions designed to target the five factors shown in this study to influence the 




With the use of more sophisticated analytic techniques than typically employed in 
previous research, we found that in the first few months after surgery, men’s sexual 
functioning scores and frequency of sexual activity were related to their presurgery levels 
of these factors, their age, and the degree of nerve sparing they received, but not to the 
type of prostatectomy they received. Most experienced as least some improvement in 
broadly measured sexual functioning over time from posttreatment baseline, with faster 
rates of recovery observed in those with higher pretreatment functioning. This study also 
specifically examined couples’ frequency of sexual activity after surgery. Findings were 
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encouraging, particularly for those with higher levels of sexual activity prior to surgery. 
Although surgery dampens their frequency of sexual activity, at least initially, many 
prostate cancer survivors are nonetheless engaging in some type of monthly sexual 
activity after surgery. Monthly frequencies appear to be influenced by five within-men 
factors, suggesting multiple targets for intervention for couples who wish to improve 
their sexual experiences. Further examining the construct “sexual activity” might enhance 
the outcomes of intervention research, particularly when the goal is to increase sexual 
intimacy and sexual satisfaction. This study provides additional information for men and 
their partners in making treatment decisions, setting realistic expectations, and seeking 
















The next section is about your current sexual function and sexual satisfaction. Many of 
the questions are very personal, but they will help us understand the important issues that 
you face every day. Remember, THIS SURVERY IS COMPLETELY 
CONFIDENTIAL. Please answer honestly about THE LAST 4 WEEKS ONLY. 
 
1. How would you rate each of the following during the last 4 weeks? 
Very 
       Poor  
       To   
 Very 
(Circle ONE number on each line)   None Poor Fair Good
 Good 
a. Your level of sexual desire……………… 1 2 3 4
 5 
b. Your ability to have an erection ………… 1 2 3 4
 5 
c. Your ability to reach orgasm……………..  1 2 3 4
 5 
 
2. How would you describe the usual QUALITY of your erections during the last 4 
weeks? 
 
(Circle ONE number on each line)    
None at all…………………….……………………. 1 
Not firm enough for sexual activity ………………. 2 
Firm enough for masturbation and foreplay only…. 3 
Firm enough for intercourse….……………………. 4 
 
3. How would you describe the FREQUENCY of your erections during the last 4 
weeks? 
 
(Circle ONE number on each line)    
I NEVER had an erection when I wanted one……... ……………………….1 
I had an erection LESS THAN HALF the time I wanted one……………….2 




I had an erection MORE THAN HALF the time I wanted one.……………,.4 
I had an erection WHENEVER I wanted one……... ………………………..5 
 
4. How often have you awakened in the morning or night with an erection during 
the last 4 weeks? 
 
(Circle ONE number on each line)    
Never………………………….……………………. 1 
Less than once a week……………………………… 2 
About once a week…………………………………. 3 
Several times a week………….……………………. 4 
Daily………………………….……………………. 5 
 
5. During the last 4 weeks, how often did you have any sexual activity?  
 
(Circle ONE number on each line)    
None at all…………………….……………………. 1 
Less than once a week……………………………… 2 
About once a week…………………………………. 3 
Several times a week………….……………………. 4 
Daily………………………….……………………. 5 
 
6. During the last 4 weeks, how often did you have sexual intercourse?  
 
(Circle ONE number on each line)    
None at all…………………….……………………. 1 
Less than once a week……………………………… 2 
About once a week…………………………………. 3 
Several times a week………….……………………. 4 
Daily………………………….……………………. 5 
 
7. Overall, how would you rate your ability to function sexually during the last 4 
weeks?  
 
(Circle ONE number on each line)    




Very good…………………….……………………. 5 
 
8. How big a problem during the last 4 weeks, if any, has each of the following 
been for you? 
     No    Very Small    Small Moderate       
Big 
(Circle ONE number on each line) Problem      Problem   Problem  Problem    
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Problem   
a. Your level of sexual desire      0  1  2      3 
 4  
b. Your ability to have an erection      0  1  2      3 
 4 
c. Your ability to reach orgasm1     0  1  2      3 
 4 
 
9. Overall, how big a problem has your sexual function or lack of sexual function been for 
you during the last 4 weeks? 
 
(Circle ONE number on each line)    
No problem………………….……………………. 1 
Very small problem………………………………… 2 
Small problem……………………………………. 3 
Moderate problem…………….……………………. 4 
Big problem………………….……………………. 5 
 
Questions Used Added by Study Team 
 
1. Which of the following, if any, have you used in the past 4 weeks to improve your 
erections? 
 
(Circle ALL that apply)    
None at all…………………….……………………. 0 
Vacuum erection device (Erect-aid)………………. 1 
Penile injection therapy…………………………… 2 
Penile prosthesis……………………………………. 3 
Muse (intra-urethral alprostadil)..…………………. 4 
Medication (Viagra, Levitra, or Cialis)……………. 5 
Other _______________________………………. 6 
 
2. How would you rate each of the following during the last 4 weeks? 
 
Very 
       Poor  
       To   
 Very 
(Circle ONE number on each line)   None Poor Fair Good
 Good 
e. Your ability to satisfy your spouse or partner   
    sexually 
    without using medication    1 2 3 4
 5 
    with medication (leave blank if you do not use 1 2 3 4
 5 











PRELIMINARY ANALYSES FOR AIMS 1 AND 2 
 
 
Below are the results of the preliminary analyses for Aims 1 and 2: 
Aim 1 (Sexual Functioning) Unconditional Baseline Model: 
π0i = β00 + roi 
where for the fixed effects, β00 = mean overall level of sexual functioning across men. 
Parameter r0i represents variance in the levels of sexual functioning; therefore, a 
significant variance component suggests that including level-2 between-subjects factors 
is justified. 
Results suggest that there is significant variance in the outcome variable, χ2(486) 
= 8430.36, p<.001 (see Table 3).  
Aim 1 (Sexual Functioning) Unconditional Random Growth Model: 
π0i = β00 + roi 
π1i = β10 + r1i 
where for the fixed effects, β00 = mean initial level of sexual functioning across men at 
baseline posttreatment and β10 = mean monthly growth in levels of sexual functioning. 
Parameter r1i represents variance in the levels of sexual functioning across men over time; 
therefore, a significant variance component suggests that including level-2 between-




Results suggested significant variance components for the intercept, χ2(486) = 
4263.17, p<.001, and on the slope of time, χ2(486) = 1267.25, p<.001 (see Table 3). 
Further, a likelihood ratio test comparing the unconditional random growth model with 
the unconditional model suggested that the model with the random effect on time was a 
better fit than the one with only a random effect on the intercept, χ2(2) = 60.57, p<.001. 
Finally, 29% of the within-person variance is explained by linear time (r2 = .29).  
Aim 2 (Sexual Activity) Unconditional Baseline Model: 
π0i = β00 + roi 
where for the fixed effect, β00 = mean overall rates of sexual activity across men. 
Parameter r0i represents variance in the rate of sexual activity across men; therefore, a 
significant variance component suggests that including level-2 between-subjects factors 
is justified. 
Results suggest that there is significant variance in the outcome variable, χ2(486) 
= 6748.82, p<.001 (see Table 3).  
Aim 2 (Sexual Activity) Unconditional Random Growth Model 
π0i = β00 + roi 
π1i = β10 + r1i 
where for the fixed effects, β00 = mean initial rates of sexual activity across men at 
baseline posttreatment and β10 = mean monthly growth in sexual activity across men over 
time. Parameter r1i represents variance in the rate of sexual activity across men over time; 
therefore, a significant variance component suggests that including level-2 between-
subjects factors is justified. 
 Results suggested significant variance components for the intercept, χ2(486) = 
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3192.18, p<.001, and on the slope of time, χ2(486) = 755.70, p<.001 (see Table 3). 
Further, a likelihood ratio test comparing the unconditional random growth model with 
the unconditional model suggested that the model with the random effect on time was a 
better fit than the one with only a random effect on the intercept, χ2(2) = 60.57, p<.001. 




























Table 3  
Estimation of Fixed Effects (with Robust Standard Errors) and Random Effects  
for Aim 1 and Aim 2 Preliminary Analyses 
 
 
Note. Sexual Functioning is scaled 0-100, Sexual Activity is scaled 1-5. For p values: 









Unconditional Baseline Model Coefficient(SE) 	 Coefficient(SE) 	
For INTERCEPT, π0	 	 	 	 	
Intercept, β00 29.29(0.99)***  2.14(.04)*** 
INTERCEPT, r0 443.83 (21.07)***  0.71(.84)*** 
level-1, e 165.44(12.86)  0.34(.58) 
Unconditional Growth Model Coefficient(SE)  Coefficient(SE) 
For INTERCEPT, π0    
     Intercept, β00 25.18(0.96)***  2.12(.04)*** 
     INTERCEPT, r0 384.12(19.60)***  0.74(.86)*** 
For TIME (MONTHS) slope, πi    
     Intercept, β10 0.26(.02)***  0.001 (.001) 
     MONTHS slope, r1 0.14(.37)***  0.001 (.01)*** 
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